Ketamine
Dissociative anesthetic for procedural sedation, analgesia, and treatment-resistant depression.
Ketamine is a Schedule III controlled substance. DEA licensing required for purchase.
Product Overview
Ketamine hydrochloride injection is a rapid-acting dissociative anesthetic indicated for induction and maintenance of anesthesia. Our ketamine products are manufactured under DEA-licensed conditions with complete chain of custody documentation.
| Product | Concentration | Fill Volume | Total Content | Container | BUD |
|---|---|---|---|---|---|
| Ketamine 10% MDVC-III | 100 mg/mL | 5 mL | 500 mg/vial | MDV | 12 months |
| Ketamine 10% SDVC-III | 100 mg/mL | 2 mL, 5 mL | 200 mg or 500 mg/vial | SDV | 24 months |
| Ketamine 1% SDVC-III | 10 mg/mL | 5 mL | 50 mg/vial | SDV | 24 months |
Request Product Information
Contact our team for specifications, pricing, and availability.